Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -216.72%-380.92K | 54.15%-1.28M | 49.11%-577.59K | 23.58%-706.27K | 54.51%-322.32K | 1,477.65%326.35K | -13,751.45%-2.79M | -3,547.24%-1.13M | -3,435.22%-924.14K | -2,600.59%-708.53K |
| Net income from continuing operations | 506.61%1.3M | -4.58%-2.52M | 17.47%-1.19M | -51.99%-1.11M | 175.48%93.34K | -165.62%-320.76K | -412.84%-2.41M | -280.79%-1.44M | -2,845.94%-728.83K | -345.45%-123.67K |
| Operating gains losses | -513.91%-145K | 852.68%188.17K | 483.33%87.5K | --125K | ---711 | ---23.62K | ---25K | --15K | --0 | ---- |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Remuneration paid in stock | -91.36%40.35K | 77.48%775.46K | --8.6K | -63.27%122.33K | --177.39K | 349.84%467.14K | --436.92K | --0 | --333.08K | --0 |
| Deferred tax | ---- | 119.08%1.26M | ---- | ---- | ---- | ---- | 100.47%577.34K | ---- | ---- | ---- |
| Other non cashItems | -695.14%-1.55M | -152.36%-1.27M | -67.90%-466.75K | 13.83%-125.14K | -512.46%-484.08K | -12,046.71%-195.56K | -7,253.50%-503.86K | -10,840.38%-278K | -5,793.63%-145.22K | ---79.04K |
| Change In working capital | -106.39%-25.51K | 133.13%286.28K | -2,744.21%-283.88K | 172.88%279.27K | 76.76%-108.26K | 7,824.99%399.15K | -909.65%-864.14K | -902.11%-9.98K | -36,146.47%-383.17K | -13,910.32%-465.82K |
| -Change in receivables | -127.40%-64.9K | 83.75%-91.27K | 122.08%51.1K | 75.28%-67.65K | -545.97%-311.62K | 3,008.89%236.9K | -690.37%-561.57K | -12,653.11%-231.47K | -3,438.79%-273.71K | -756.55%-48.24K |
| -Change in prepaid assets | -90.54%21.59K | 190.13%456.76K | -111.22%-23.32K | 119.20%20.13K | 138.07%231.77K | 27,824.54%228.17K | -8,466.86%-506.78K | 2,747.01%207.74K | -5,165.85%-104.86K | -19,708.12%-608.83K |
| -Change in payables and accrued expense | 127.01%17.81K | -138.79%-79.21K | -2,366.51%-311.67K | 7,208.88%326.8K | -114.85%-28.41K | -1,834.82%-65.92K | 3,577.38%204.21K | 58.66%13.75K | 50.06%-4.6K | 3,141.54%191.25K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -216.72%-380.92K | 54.15%-1.28M | 49.11%-577.59K | 23.58%-706.27K | 54.51%-322.32K | 1,477.65%326.35K | -13,751.45%-2.79M | -3,547.24%-1.13M | -3,435.22%-924.14K | -2,600.59%-708.53K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -124.97%-3.2M | -95.74%-8.02M | 33.85%-1.2M | 85.35%-242.69K | -763.74%-5.15M | -5,068.13%-1.42M | -3,265.01%-4.09M | -23,131.55%-1.81M | -59,936.60%-1.66M | -440.51%-596.16K |
| Net PPE purchase and sale | -124.97%-3.2M | -95.74%-8.02M | 33.85%-1.2M | 85.35%-242.69K | -763.74%-5.15M | -5,068.13%-1.42M | -3,265.01%-4.09M | -23,131.55%-1.81M | -59,936.60%-1.66M | -440.51%-596.16K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -124.97%-3.2M | -95.74%-8.02M | 33.85%-1.2M | 85.35%-242.69K | -763.74%-5.15M | -5,068.13%-1.42M | -3,265.01%-4.09M | -23,131.55%-1.81M | -59,936.60%-1.66M | -440.51%-596.16K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -54.06%9.9M | 42.66%9.72M | 117.90%172.5K | 2,490.35%21.54M | 6.82M | 79.17K | ||||
| Net common stock issuance | ---- | -53.13%9.72M | 42.82%9.72M | --0 | ---- | ---- | 2,394.82%20.74M | --6.81M | ---66.66K | ---- |
| Proceeds from stock option exercised by employees | ---- | -78.28%172.5K | --0 | 18.29%172.5K | ---- | ---- | --794.38K | --7.88K | --145.83K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | -54.06%9.9M | 42.66%9.72M | 117.90%172.5K | ---- | ---- | 2,490.35%21.54M | --6.82M | --79.17K | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | 3.83%16.27M | 1,446.51%15.67M | -29.48%8.32M | -36.39%9.1M | 1,414.86%14.57M | 1,446.51%15.67M | 213.32%1.01M | 1,038.77%11.8M | 1,249.71%14.3M | 163.78%961.74K |
| Current changes in cash | -226.66%-3.58M | -95.90%600.31K | 105.52%7.94M | 68.96%-776.46K | -141.02%-5.47M | -2,040.80%-1.1M | 2,024.62%14.65M | 16,734.30%3.87M | -10,601.47%-2.5M | 1,819.43%13.34M |
| End cash Position | -12.94%12.68M | 3.83%16.27M | 3.83%16.27M | -29.48%8.32M | -36.39%9.1M | 1,414.86%14.57M | 1,446.51%15.67M | 1,446.51%15.67M | 1,038.77%11.8M | 1,249.71%14.3M |
| Free cash from | -226.66%-3.58M | -34.98%-9.3M | 39.72%-1.78M | 63.22%-948.96K | -319.38%-5.47M | -2,040.80%-1.1M | -4,754.87%-6.89M | -12,593.63%-2.95M | -10,940.17%-2.58M | -855.59%-1.3M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.